Login

Franck Mouthon, co-founder and CEO of Theranexus 00:00:00

Share On Facebook Share On Twitter

Franck Mouthon, co-founder and CEO of Theranexus

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Addressing the Impact of ACI: Innovating Therapeutic Solutions for Cannabinoid Intoxication |Simon Allen, CEO, Anebulo Pharmaceuticals Inc.
00:10:00
Chart Industries CEO: Mastering the Hydrogen Value Chain | Jillian C. Evanko - CEO of Chart Industries, Inc.
00:10:00
Highland Copper: U.S. Copper Projects and Growth Strategy Presentation.
00:10:00
Maximizing Tax Savings and Investment Potential with HSAs |Lauren Zangardi Haynes, Founder, Spark Financial Advisors, LLC.
00:10:00
2023 Outlook for Australia's Oil and Gas: Insights with Managing Director Ian Lusted
00:10:00
Crayon's Role in AI Innovation: A Focus on Responsible AI | Melissa Mulholland, Chief Executive Officer of crayon group holding asa
00:10:00
Clayton Allen, SVP at Height Capital Markets, discusses trade policy and geopolitical risks on "Worldwide Exchange."
00:10:00
Kerry Express Thailand's IPO Soars: Shares Surge 161% | Alex Ng - CEO of Kerry Express Thailand PCL
00:00:00
Genovis | Fredrik Olsson, CEO, Genovis
00:10:00
We invest in fearless founders|Brandon Brooks,Founding Partner,overlook vc
00:10:00
Mad Money: Aurinia Pharmaceuticals CEO: Speculative Salvation? | Peter Greenleaf, CEO, AURINIA PHARMACEUTICALS INC
00:10:00
Artificial Intelligence (AI), Security, Internet of Things (IoT) and emerging Computational Biotech, Quantum Computing|Ashot Arzumanyan,Partner,SmartGateVC

© 2017 - Neuhu+